$TMC The Metals Company is positioned amid the critical metals surge with rights to vast polymetallic nodules in the Pacific’s Clarion Clipperton Zone, estimated to hold $23.6 billion in nickel, copper, cobalt, and manganese. These metals are vital for EV batteries and renewable tech. However, the company faces significant hurdles, including regulatory uncertainty as it seeks U.S. NOAA approval instead of the stalled international framework, and environmental opposition from multiple countries. Being pre-revenue and years from production, with cash reserves dwindling and heavy capital needs ahead, $TMC remains a speculative play despite the booming demand backdrop.
$TLRY Tilray Brands posted record fiscal 2026 revenue of about $915 million, edging closer to its $1 billion target, with adjusted EBITDA and net income improving. Yet, the stock hasn’t rallied strongly, partly because adjusted earnings missed expectations and GAAP losses persisted. The company’s pivot away from cannabis—now only 29% of sales—toward alcoholic beverages and pharmaceuticals, combined with dilution from debt-for-equity swaps, keeps investors cautious despite ongoing U.S. legalization momentum.
$SKHY SK Hynix announced a bold plan to repurchase and permanently cancel 3.3% of its shares, marking the largest treasury-share cancellation ever by a South Korean company. This $29 billion buyback aims to unlock value by reducing share count and boosting earnings per share, especially given the stock’s relatively low price-to-earnings ratio near 8. The move also signals confidence in intrinsic value and comes with an expanded shareholder return framework promising at least 50% of free cash flow back to investors through 2027.
$MSFT Microsoft recently paid out a massive $6.8 billion dividend while simultaneously investing $116 billion in AI-related capital expenditures in fiscal 2026, highlighting its aggressive push into AI infrastructure. CFO Amy Hood confirmed the company expects to remain free cash flow positive in fiscal 2027 despite rising capex, which could reach $175 billion. This balance of rewarding shareholders and fueling AI growth underscores Microsoft’s dual focus on innovation and income generation.
$VOO With markets near all-time highs, concerns about a potential bear market are rising. Investors are reminded that downturns are part of the cycle and historically followed by new bull runs. A simple strategy to weather volatility is to keep buying low-cost S&P 500 index funds like $VOO, leveraging dollar-cost averaging to accumulate shares during dips. Diversifying away from high-flying tech stocks into steady dividend payers in consumer staples or utilities can also help reduce risk and provide income during uncertain times.
$UBS UBS has raised its S&P 500 year-end target to 8,100 from 7,900, reflecting confidence in a strong profit engine despite recent market volatility. The bank’s outlook is driven by robust earnings growth—nearly 80% of S&P 500 companies beat estimates recently—and broad sector participation beyond just megacap tech. UBS expects continued support from U.S. economic growth, accommodative monetary policy, and AI adoption, suggesting further upside potential of about 5.5% into year-end.
$ORCL Oracle’s cloud business has gained momentum through a massive $300 billion backlog fueled by its partnership with OpenAI, offering database-native AI and cost-efficient cloud infrastructure. However, concerns linger over OpenAI’s financial losses and Oracle’s rising debt, which hit $129.5 billion after heavy capital spending. Negative free cash flow and a 56% stock drop from peak levels reflect investor skepticism about the payoff timeline for these investments.
$TRU TransUnion’s shares have declined over 27% in five years, but discounted cash flow analysis suggests the stock may be undervalued by nearly 50%, based on steady free cash flow generation from its data and analytics business. Trading near industry-average P/E multiples, $TRUpresents a mixed picture where cautious investors weigh margin pressures and funding costs against its ability to convert revenue into cash flow.
$NTRA Billionaire Stanley Druckenmiller has made cancer-testing firm Natera his largest portfolio holding, adding shares even as prices reached record highs. Natera’s Signatera test detects tumor DNA fragments to monitor cancer recurrence, a service with steady demand regardless of economic cycles. The company’s latest quarter showed revenue growth of 37.7%, beating estimates, driven by a 57% jump in oncology test volume, reinforcing its appeal as a resilient healthcare play.
$V ARK Invest’s Cathie Wood continues to accumulate Circle despite a 42% drop over the past year, arguing that traditional analysts fail to grasp the disruptive potential of Circle’s USDC stablecoin business. While Circle’s stock has actually gained about 184% since its IPO, Wall Street remains divided with price targets ranging widely from $37 to $173. Circle’s revenue growth and recent profitability highlight the evolving dynamics in digital payments and stablecoins, even as market sentiment remains fragmented.
U.S. markets are currently closed for the weekend and will reopen tomorrow morning at 9:30 AM ET.
Did you know?
The concept of dollar-cost averaging, where investors consistently buy a fixed dollar amount of a stock or fund regardless of price, can reduce the impact of volatility and potentially lower the average cost per share over time—making it a powerful strategy during market downturns.
Disclaimer
This content is for entertainment and discussion purposes only. It is based on publicly available headlines and social media commentary, which can be messy and ever-evolving. We are not financial advisors, and this is not investment advice. The publisher may hold positions in securities mentioned. We aim to keep things accurate—if you catch something off, please let us know.
Powered by - Trading Watch Premium
This data is 100% free and is made possible by our Monthly Supporters.
No Comments